Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Sah P, Vilches TN, Moghadas SM, Gondi S, Schneider EC, Singer J, Chokshi DA, Galvani AP, Return on investment of the COVID-19 vaccination campaign in New York City, JAMA Network Open 2022, 5(11): e2243127.
Moghadas SM, Sah P, Shoukat A, Meyers LA, Galvani AP, Population immunity against COVID-19 in the United States, Annals of Internal Medicine 2021, 174(11):1586-1591.
Wells CR, Townsend JP, Pandey A, Moghadas SM, Krieger G, Singer BH, McDonald RH, Fitzpatrick MC, Galvani AP, Optimizing COVID-19 quarantine and testing strategies, Nature Communications 2021, 21: 356.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Chen L, Mukerjee G, Dorfman R, Moghadas SM, Disease risk assessment using a Voronoi-based network analysis of genes and variants scores, Frontiers in Genetics 2017, 8: 29.
Moghadas SM, Shoukat A, Espindola A, Pereira RS, Abdirizak F,Laskowski M, Viboud C, Chowell G, Asymptomatic transmission and the dynamics of Zika infection, Scientific Reports 2017, 7: 5829.
Maghdoori S, Moghadas SM, Assessing the effect of patient screening and isolation on curtailing Clostridium difficile infection in hospital settings, BMC Infectious Diseases 2017, 17: 384.
Champredon D, Moghadas SM, Quantifying the contribution of asymptomatic infection to the cumulative incidence, Epidemiology and Infection 2017, 145: 1256–1258.
Moghadas SM, Mathematical modelling of tuberculosis, Mathematical Population Studies 2017, 24: 1-2.
Knipl D, Röst G, Moghadas SM, Population dynamics of epidemic and endemic states of drug-resistance emergence in infectious diseases, PeerJ 2017, 5: e2817.
Brauer F, Xiao Y, Moghadas SM, Drug-resistance in an age-of-infection model, Mathematical Population Studies 2017, 24: 64–78.
Espindola A, Varughese M, Laskowski M, A. Shoukat, Heffernan J, Moghadas SM, Strategies for halting the rise of MDR-TB epidemic: assessing the effect of early case detection and isolation, International Health 2017, 9: 80–90.
Shoukat A, Espindola A, Röst G, Moghadas SM, How the interval between primary and booster vaccination affects long-term disease dynamics, Mathematical Biology and Biological Physics 2017, 60–71.
Charania N, Moghadas SM, Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b, BMC Public Health 2017, 17: 705.